As expected, the phosphorylation level of AKT was suppressed with the increase in EPS11 treatment time and showed the same trend as that of βIII-tubulin expression (Figure 8E), which confirms that βIII-tubulin associated anoikis is one of the main reasons for EPS11 killing cancer cells. This evidence concerns the gene AKT1 and cancer.